Beijing Tiantan Biological Products Corporation Limited’s Net Profit Rose 4.5% in First Three Quarters of 2022

Beijing Tiantan Biological Products Corporation Limited (北京天坛生物制品股份有限公司) (600161.SH) reported a net profit of 825.9 million yuan in the first three quarters of 2022, up 4.5% year-on-year.

Meanwhile, the company posted 2.9 billion yuan in revenue, up 3.4% year-on-year.

At the end of the reporting period, it had 12.9 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 14.7%.